← Eichor
Condition: Malignant Peritoneal Mesothelioma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Peritoneal Mesothelioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Per
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT04847063Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06885697CT-95 in Advanced Cancers Associated With Mesothelin Expression
Phase 1 · 9 location(s) · Context Therapeutics Inc. · NCT06756035PTC-Guided Therapy for Peritoneal Mesothelioma
NA · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07330271A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1 · 16 location(s) · IDEAYA Biosciences · NCT07277413A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Phase 2 · 13 location(s) · Memorial Sloan Kettering Cancer Center · NCT06057935A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06543069Immune Microenvironment and Gene Expression Profiling in Mesothelioma
Phase N/A · 10 location(s) · Istituto Oncologico Veneto IRCCS · NCT06581549Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Phase 2 · 40 location(s) · National Cancer Institute (NCI) · NCT05001880Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT01617382
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.